Pandaily

Pandaily

Share this post

Pandaily
Pandaily
China Drugmaker Plunges After Wanda Director Doubts Covid Treatment Efficacy
Copy link
Facebook
Email
Notes
More

China Drugmaker Plunges After Wanda Director Doubts Covid Treatment Efficacy

Apr 20, 2022
∙ Paid

Share this post

Pandaily
Pandaily
China Drugmaker Plunges After Wanda Director Doubts Covid Treatment Efficacy
Copy link
Facebook
Email
Notes
More
Share
Wang Sicong
Wang Sicong (Source: Sohu)

The stock price of traditional Chinese medicine-maker Yiling Pharmaceutical plunged after Wang Sicong, founder of Prometheus Capital and director of Wanda Group, reposted a video on April 14 on Weibo that questioned whether the World Health Organization had ever recommended the firm’s Lianhua Qingwen capsules as Covid-19 treatm…

Keep reading with a 7-day free trial

Subscribe to Pandaily to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Pandaily
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More